Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Binh Thanh Nguyen | - |
dc.contributor.author | Park, Min | - |
dc.contributor.author | Yoo, Young Sook | - |
dc.contributor.author | Kang, Min-Jung | - |
dc.date.accessioned | 2024-01-19T22:31:07Z | - |
dc.date.available | 2024-01-19T22:31:07Z | - |
dc.date.created | 2021-09-03 | - |
dc.date.issued | 2018-07 | - |
dc.identifier.issn | 0003-2654 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/121202 | - |
dc.description.abstract | We developed an assay for diagnosing rheumatoid arthritis (RA) by capillary electrophoresis with the laser-induced fluorescence detection (CE-LIF) of antibodies against cyclic citrullinated peptides (CCPs) using fluorescein isothiocyanate-labeled F-CCP11A and F-CCP. The CCPs were incubated overnight with a purified antibody against CCP and then injected into the CE-LIF system to estimate complex concentration. The immunocomplexes and free peptides were separated within 5 min, the LOD and LOQ values of the immunoassay are 0 1 mu g mL(-1) and 0 3 mu g mL(-1), respectively. The calibration curves for the immunocomplex had a coefficient of determination of 0.98. The reproducibility of the CE-LIF based immunoassay when using F-CCP11A and F-CCP was less than 5% and the accuracy ranged between 89 and 103%. The applicability of the assay was evaluated using serum samples from RA patients and healthy control subjects. We found that the sensitivity and specificity for RA diagnosis were 100% and 83.3%, respectively, for F-CCP11A and 100% and 90%, respectively, for F-CCP. These results demonstrate that the CE-LIF method can be useful for quantitative immunoassay development. | - |
dc.language | English | - |
dc.publisher | Royal Society of Chemistry | - |
dc.title | Capillary electrophoresis-laser-induced fluorescence (CE-LIF)-based immunoassay for quantifying antibodies against cyclic citrullinated peptides | - |
dc.type | Article | - |
dc.identifier.doi | 10.1039/c8an00714d | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | Analyst, v.143, no.13, pp.3141 - 3147 | - |
dc.citation.title | Analyst | - |
dc.citation.volume | 143 | - |
dc.citation.number | 13 | - |
dc.citation.startPage | 3141 | - |
dc.citation.endPage | 3147 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000441407700022 | - |
dc.identifier.scopusid | 2-s2.0-85049072874 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Analytical | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | EARLY RHEUMATOID-ARTHRITIS | - |
dc.subject.keywordPlus | COMPETITIVE IMMUNOASSAY | - |
dc.subject.keywordPlus | ANTIPERINUCLEAR FACTOR | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | SERUM | - |
dc.subject.keywordPlus | LIF | - |
dc.subject.keywordPlus | AUTOANTIBODY | - |
dc.subject.keywordPlus | STRATEGIES | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | MARKER | - |
dc.subject.keywordAuthor | anti-CCP | - |
dc.subject.keywordAuthor | CE-LIF | - |
dc.subject.keywordAuthor | Immunoassay | - |
dc.subject.keywordAuthor | RA diagnosis | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.